✦ LIBER ✦

A preliminary clinical evaluation of the therapeutic effects of hydroxyurea in patients with myelogenous leukaemia

✍ Scribed by D. Quaglino; U. Torelli; G. Emilia

Book ID: 113144938
Publisher: Elsevier Science
Year: 1966
Weight: 511 KB
Volume: 2
Category: Article
ISSN: 0014-2964
DOI: 10.1016/0014-2964(66)90091-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of hydroxyurea in the treatment

Efficacy of hydroxyurea in the treatment of a patient with erythrodermic psoriasis and chronic myelogenous leukaemia

✍ Luis Miguel Taveira; Cristina Gonçalves; António Paiva; Manuela Selores; Madalen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 920 KB

Efficacy of hydroxyurea in the treatment

Efficacy of hydroxyurea in the treatment of a patient with erythrodermic psoriasis and chronic myelogenous leukaemia

✍ Luis Miguel Taveira; Cristina Gonçalves; António Paiva; Manuela Selores; Madalen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

A multicentre study of a randomized ther

A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph1-positive chronic myelogenous leukaemia: Interferon alfa-2b and hydroxyurea with or without cytosine arabinoside, preliminary results

✍ François Guilhot; Jean-Pierre Lamagnère; Jean Luc Harousseau; Hervé Tilly; Phili 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 119 KB

Hydroxyurea-Induced gangrene of the toes

Hydroxyurea-Induced gangrene of the toes in a patient with chronic myelogenous leukemia

✍ Yasuda, Norimasa; Ohmori, Sei-ichi; Usui, Tadao 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 3 views

To the Editor: Semenzato et al. proposed new criteria for large granular lymphocyte (LGL) leukemia because patients with low levels of GL were similar to those with levels greater than 2,000 GL/l [1]. LGL leukemia is a GL proliferative disease often accompanied by pure red cell aplasia (PRCA). T-cel

Gangrene of the toes in a patient with c

Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy

✍ E. Leo; A. Krämer; A. Hochhaus; F. Krasniqi; R. Hehlmann; A. Ho 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 51 KB

The pharmacokinetics of subcutaneous cyt

The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.

✍ ML Slevin; EM Piall; GW Aherne; A Johnston; MC Sweatman; TA Lister 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB